{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:12:58Z","timestamp":1779225178254,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtbi.2022.111394","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T19:47:14Z","timestamp":1671824834000},"page":"111394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Oncolytic virus treatment of human breast cancer cells: Modelling therapy efficacy"],"prefix":"10.1016","volume":"560","author":[{"given":"Brock D.","family":"Sherlock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5572-6832","authenticated-orcid":false,"given":"Adelle C.F.","family":"Coster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"52","key":"10.1016\/j.jtbi.2022.111394_b1","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1038\/sj.onc.1209037","article-title":"Oncolytic viral therapies \u2013 the clinical experience","volume":"24","author":"Aghi","year":"2005","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.jtbi.2022.111394_b2","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J. Gen. Virol."},{"issue":"25","key":"10.1016\/j.jtbi.2022.111394_b3","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111394_b4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.mbs.2006.10.006","article-title":"Population models with singular equilibrium","volume":"208","author":"Berezovskaya","year":"2007","journal-title":"Math. Biosci."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111394_b5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph-node status, and survival in 24,740 breast-cancer cases","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.jtbi.2022.111394_b6","first-page":"5453","article-title":"CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity","volume":"61","author":"Chen","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111394_b7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0771-050X(80)90013-3","article-title":"A family of embedded Runge-Kutta formulae","volume":"6","author":"Dormand","year":"1980","journal-title":"J. Comput. Appl. Math."},{"issue":"6","key":"10.1016\/j.jtbi.2022.111394_b8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.jtbi.2022.111394_b9","first-page":"798","article-title":"A phase I study of onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer","volume":"6","author":"Ganly","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.jtbi.2022.111394_b10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17425247.2019.1617269","article-title":"Achieving systemic delivery of oncolytic viruses","volume":"16","author":"Hill","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jtbi.2022.111394_b11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jtbi.2019.08.002","article-title":"Oncolytic virotherapy for tumours following a Gompertz growth law","volume":"480","author":"Jenner","year":"2019","journal-title":"J. Theoret. Biol."},{"issue":"6","key":"10.1016\/j.jtbi.2022.111394_b12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11538-018-0424-4","article-title":"Mathematical modelling of the interaction between cancer cells and an oncolytic virus: Insights into the effects of treatment protocols","volume":"80","author":"Jenner","year":"2018","journal-title":"Bull. Math. Biol."},{"issue":"4","key":"10.1016\/j.jtbi.2022.111394_b13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3934\/mbe.2015.12.841","article-title":"Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics","volume":"12","author":"Kim","year":"2015","journal-title":"Math. Biosci. Eng."},{"issue":"9","key":"10.1016\/j.jtbi.2022.111394_b14","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jtbi.2022.111394_b15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jtbi.2010.01.009","article-title":"ODE models for oncolytic virus dynamics","volume":"263","author":"Komarova","year":"2010","journal-title":"J. Theoret. Biol."},{"issue":"3","key":"10.1016\/j.jtbi.2022.111394_b16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/bjc.1964.55","article-title":"Dynamics of tumor growth","volume":"18","author":"Laird","year":"1964","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.jtbi.2022.111394_b17","doi-asserted-by":"crossref","DOI":"10.1007\/s11538-020-00751-w","article-title":"Optimizing the timing and composition of therapeutic phage cocktails: A control-theoretic approach","volume":"82","author":"Li","year":"2020","journal-title":"Bull. Math. Biol."},{"issue":"1","key":"10.1016\/j.jtbi.2022.111394_b18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-6150-1-6","article-title":"Mathematical modeling of tumor therapy with oncolytic viruses: Regimes with complete tumor elimination within the framework of deterministic models","volume":"1","author":"Novozhilov","year":"2006","journal-title":"Biol. Direct"},{"key":"10.1016\/j.jtbi.2022.111394_b19","series-title":"Oxford Textbook of Cancer Biology","author":"Pezzella","year":"2019"},{"issue":"6","key":"10.1016\/j.jtbi.2022.111394_b20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/1097-0142(195611\/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7","article-title":"Studies on the use of viruses in the treatment of carcinoma of the cervix","volume":"9","author":"Smith","year":"1956","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jtbi.2022.111394_b21","first-page":"1317","article-title":"Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery","volume":"63","author":"Wein","year":"2003","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.jtbi.2022.111394_b22","first-page":"3501","article-title":"Viruses as antitumor weapons","volume":"61","author":"Wodarz","year":"2001","journal-title":"Defin. Cond. Tumor Remission"},{"issue":"3","key":"10.1016\/j.jtbi.2022.111394_b23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/wsbm.1332","article-title":"Computational modeling approaches to the dynamics of oncolytic viruses","volume":"8","author":"Wodarz","year":"2016","journal-title":"WIREs Syst. Biol. Med."},{"issue":"4","key":"10.1016\/j.jtbi.2022.111394_b24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1006\/bulm.2001.0245","article-title":"Modeling and analysis of a virus that replicates selectively in tumor cells","volume":"63","author":"Wu","year":"2001","journal-title":"Bull. Math. Biol."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251932200385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251932200385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:35:50Z","timestamp":1758386150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002251932200385X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"alternative-id":["S002251932200385X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2022.111394","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic virus treatment of human breast cancer cells: Modelling therapy efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2022.111394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111394"}}